174 related articles for article (PubMed ID: 17855005)
1. Open-label, long-term safety study of cevimeline in the treatment of postirradiation xerostomia.
Chambers MS; Jones CU; Biel MA; Weber RS; Hodge KM; Chen Y; Holland JM; Ship JA; Vitti R; Armstrong I; Garden AS; Haddad R
Int J Radiat Oncol Biol Phys; 2007 Dec; 69(5):1369-76. PubMed ID: 17855005
[TBL] [Abstract][Full Text] [Related]
2. Cevimeline for the treatment of postirradiation xerostomia in patients with head and neck cancer.
Chambers MS; Posner M; Jones CU; Biel MA; Hodge KM; Vitti R; Armstrong I; Yen C; Weber RS
Int J Radiat Oncol Biol Phys; 2007 Jul; 68(4):1102-9. PubMed ID: 17379432
[TBL] [Abstract][Full Text] [Related]
3. A double-blind, randomized, placebo-controlled study of cevimeline in Sjögren's syndrome patients with xerostomia and keratoconjunctivitis sicca.
Petrone D; Condemi JJ; Fife R; Gluck O; Cohen S; Dalgin P
Arthritis Rheum; 2002 Mar; 46(3):748-54. PubMed ID: 11920411
[TBL] [Abstract][Full Text] [Related]
4. Effectiveness of cevimeline to improve oral health in patients with postradiation xerostomia.
Witsell DL; Stinnett S; Chambers MS
Head Neck; 2012 Aug; 34(8):1136-42. PubMed ID: 22231734
[TBL] [Abstract][Full Text] [Related]
5. Therapeutic effect of cevimeline on dry eye in patients with Sjögren's syndrome: a randomized, double-blind clinical study.
Ono M; Takamura E; Shinozaki K; Tsumura T; Hamano T; Yagi Y; Tsubota K
Am J Ophthalmol; 2004 Jul; 138(1):6-17. PubMed ID: 15234277
[TBL] [Abstract][Full Text] [Related]
6. Oral pilocarpine (5mg t.i.d.) used for xerostomia causes adverse effects in Japanese.
Nakamura N; Sasano N; Yamashita H; Igaki H; Shiraishi K; Terahara A; Asakage T; Nakao K; Ebihara Y; Ohtomo K; Nakagawa K
Auris Nasus Larynx; 2009 Jun; 36(3):310-3. PubMed ID: 18635328
[TBL] [Abstract][Full Text] [Related]
7. Protection of salivary function by concomitant pilocarpine during radiotherapy: a double-blind, randomized, placebo-controlled study.
Burlage FR; Roesink JM; Kampinga HH; Coppes RP; Terhaard C; Langendijk JA; van Luijk P; Stokman MA; Vissink A
Int J Radiat Oncol Biol Phys; 2008 Jan; 70(1):14-22. PubMed ID: 17869018
[TBL] [Abstract][Full Text] [Related]
8. Effects of pilocarpine hydrochloride and cevimeline on submandibular/sublingual salivation in rat xerostomia model produced by X-ray irradiation.
Omori Y; Asari T; Maruyama K; Kusama H; Kojima M; Shibata N
Arzneimittelforschung; 2003; 53(5):342-50. PubMed ID: 12854361
[TBL] [Abstract][Full Text] [Related]
9. Comparison of the discontinuation rates and side-effect profiles of pilocarpine and cevimeline for xerostomia in primary Sjögren's syndrome.
Noaiseh G; Baker JF; Vivino FB
Clin Exp Rheumatol; 2014; 32(4):575-7. PubMed ID: 25065774
[TBL] [Abstract][Full Text] [Related]
10. Oral pilocarpine for radiation-induced xerostomia: integrated efficacy and safety results from two prospective randomized clinical trials.
Rieke JW; Hafermann MD; Johnson JT; LeVeque FG; Iwamoto R; Steiger BW; Muscoplat C; Gallagher SC
Int J Radiat Oncol Biol Phys; 1995 Feb; 31(3):661-9. PubMed ID: 7852133
[TBL] [Abstract][Full Text] [Related]
11. Clinical evaluation of a commercially available oral moisturizer in relieving signs and symptoms of xerostomia in postirradiation head and neck cancer patients and patients with Sjögren's syndrome.
Rhodus NL; Bereuter J
J Otolaryngol; 2000 Feb; 29(1):28-34. PubMed ID: 10709169
[TBL] [Abstract][Full Text] [Related]
12. The efficacy of cevimeline hydrochloride in the treatment of xerostomia in Sjögren's syndrome in southern Chinese patients: a randomised double-blind, placebo-controlled crossover study.
Leung KC; McMillan AS; Wong MC; Leung WK; Mok MY; Lau CS
Clin Rheumatol; 2008 Apr; 27(4):429-36. PubMed ID: 17899308
[TBL] [Abstract][Full Text] [Related]
13. Effect of oral pilocarpine on post-irradiation xerostomia in head and neck cancer patients: a single-center, single-blind clinical trial.
Chitapanarux I; Kamnerdsupaphon P; Tharavichitkul E; Sumitsawan Y; Sittitrai P; Pattarasakulchai T; Lorvidhaya V; Sukthomya V; Pukanhaphan N; Traisatit P
J Med Assoc Thai; 2008 Sep; 91(9):1410-5. PubMed ID: 18843872
[TBL] [Abstract][Full Text] [Related]
14. Effect of a muscarinic M3 receptor agonist on gastric motility.
Chiba T; Kudara N; Sato M; Inomata M; Orii S; Suzuki K
J Gastroenterol Hepatol; 2007 Nov; 22(11):2039-41. PubMed ID: 17914991
[TBL] [Abstract][Full Text] [Related]
15. Botulinum toxin type A as migraine preventive treatment in patients previously failing oral prophylactic treatment due to compliance issues.
Cady R; Schreiber C
Headache; 2008 Jun; 48(6):900-13. PubMed ID: 18047501
[TBL] [Abstract][Full Text] [Related]
16. Patients with head and neck cancer cured by radiation therapy: a survey of the dry mouth syndrome in long-term survivors.
Wijers OB; Levendag PC; Braaksma MM; Boonzaaijer M; Visch LL; Schmitz PI
Head Neck; 2002 Aug; 24(8):737-47. PubMed ID: 12203798
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of cevimeline vs. pilocarpine in the secretion of saliva: a pilot study.
Brimhall J; Jhaveri MA; Yepes JF
Spec Care Dentist; 2013; 33(3):123-7. PubMed ID: 23600983
[TBL] [Abstract][Full Text] [Related]
18. Cevimeline for the treatment of xerostomia in patients with Sjögren syndrome: a randomized trial.
Fife RS; Chase WF; Dore RK; Wiesenhutter CW; Lockhart PB; Tindall E; Suen JY
Arch Intern Med; 2002 Jun; 162(11):1293-300. PubMed ID: 12038948
[TBL] [Abstract][Full Text] [Related]
19. Randomized double blind, placebo-controlled study of pilocarpine administered during head and neck irradiation to reduce xerostomia.
Sangthawan D; Watthanaarpornchai S; Phungrassami T
J Med Assoc Thai; 2001 Feb; 84(2):195-203. PubMed ID: 11336078
[TBL] [Abstract][Full Text] [Related]
20. Oral pilocarpine for post-irradiation xerostomia in patients with head and neck cancer.
Johnson JT; Ferretti GA; Nethery WJ; Valdez IH; Fox PC; Ng D; Muscoplat CC; Gallagher SC
N Engl J Med; 1993 Aug; 329(6):390-5. PubMed ID: 8326972
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]